Basic Casodex Information

• INN (International Nonproprietary Name): Bicalutamide
• Brand Names Available In United Kingdom: Casodex (50 mg film-coated tablets) supplied by AstraZeneca
• ATC Code: L02BB03 (Endocrine therapy; Hormone antagonists and related agents; Anti-androgens)
• Forms & Dosages: Tablet — 50 mg and 150 mg; blisters commonly in packs of 28, 30, 60 or 100; global availability, prescription only
• Manufacturers In United Kingdom: Originator marketer — AstraZeneca (UK supply for Casodex 50 mg film-coated tablets)
• Registration Status In United Kingdom: Authorised and marketed as Casodex 50 mg film‑coated tablets; check local trust guidance for use and supply
• OTC / Rx Classification: Prescription only (Rx) in the United Kingdom

Important Instructions, Warnings And Daily-Life Integration For UK Patients (Do Read Before The Sections)

Use only on prescription.

Casodex (INN: bicalutamide) is a prescription‑only anti‑androgen supplied in the UK as 50 mg film‑coated tablets by AstraZeneca.

Keep all tablets in the original blister until use and store below 25°C, away from moisture and light.

Safety first: do not give to women or children.

Avoid use in severe liver disease; severe hepatic impairment is an absolute contraindication.

Tell your prescriber if you have a history of liver problems or if you take warfarin or other serious medicines.

Sign up to your GP or oncology nurse follow‑up for regular liver function tests during the first months of treatment.

NHS repeats and monitoring are standard — you will need a valid prescription to collect from Boots, LloydsPharmacy, Superdrug or an online UK pharmacy.

In England a prescription charge applies; prescriptions are free in Scotland, Wales and Northern Ireland.

If you miss a dose, take it when remembered unless it is almost time for the next dose; do not double up.

Practical travel checklist:

• Pack blister packs in hand luggage, keep in original packaging.
• Take a copy of your prescription or hospital patient ID letter for cross‑border travel.
• Carry contact details for your oncology nurse and GP.
• Avoid storing tablets in the hotel bathroom; keep them in a dry, cool part of your luggage.

Pharmacist counselling checklist for first collection:

• Confirm indication and dose (usually 50 mg once daily for metastatic disease).
• Explain storage below 25°C and to keep in original blister until use.
• Advise on liver monitoring schedule and signs of hepatic injury.
• Check concomitant medicines, especially warfarin.

Everyday Use & Best Practices

Morning Vs Evening Dosing

Which time suits you best is often the first question patients ask their clinician.

Casodex is typically taken once daily at the same time to build a routine and reduce missed doses.

Most UK patients choose morning dosing because it fits daily medication rhythms and NHS repeat prescription patterns.

Some patients who experience night‑time hot flashes swap to morning dosing after discussion with their oncology team.

Always check any change in timing with your prescriber to ensure it fits your overall hormonal schedule, especially if combined with LHRH analogue injections.

Taking With Or Without Meals (UK Diet Habits)

Bicalutamide can be taken with or without food.

Many people on typical UK meal patterns find taking it with breakfast or after the evening meal reduces stomach upset.

Because evening meals in the UK are often heavier, taking Casodex with a light breakfast can suit those who want to avoid gastric discomfort.

Aim for consistent timing to fit weekly or 28‑day supplies from your GP or hospital clinic.

Daily Routine Checklist:

• Pick a fixed time each day (for example, after breakfast) and stick to it.
• Use a pill box or phone reminder if you have several medicines.
• Keep the blister in a kitchen cupboard away from steam and heat, not in the bathroom.
• Bring a list of medications to each oncology or GP review for interaction checks.

Patient Travel And Work Checklist:

• Carry prescription copy or hospital letter when travelling.
• Keep tablets in hand luggage and in original blister packaging.
• Avoid high humidity storage; select a cool, dry part of your bag.

Safety Priorities

Who Should Avoid It (MHRA Warnings)

Bicalutamide must not be used by women or children; it is contraindicated in these groups.

Severe hepatic impairment is an absolute contraindication and bicalutamide is not recommended in moderate to severe liver disease.

Hypersensitivity to bicalutamide or any excipient is another contraindication.

The MHRA highlights the need for liver function monitoring and stopping the drug if significant liver injury is suspected.

Activities To Limit (Driving, Work Safety)

Some patients report dizziness or fatigue while taking Casodex.

Until you know how it affects you, take care when driving or operating heavy machinery.

Inform your employer if you carry out safety‑critical work so adjustments can be made if fatigue occurs.

If you are on warfarin or other narrow therapeutic index drugs, INR and dosing may need more frequent checks.

Contraindications Versus Precautions

When To Contact Emergency Services Or Your Oncology Team:

• Any sign of jaundice, dark urine or persistent nausea and vomiting.
• Severe rash, breathlessness, or signs of allergic reaction.
• Markedly increased fatigue or sudden weakness.

Dosage & Adjustments

General Regimen (NHS Guidance)

The usual adult dose for metastatic prostate cancer is 50 mg once daily, given with an LHRH analogue such as goserelin.

In some regions, 150 mg once daily is used as monotherapy for locally advanced non‑metastatic disease; confirm local trust policy before prescribing or changing dose.

Treatment for metastatic disease frequently continues until disease progression or unacceptable toxicity.

Special Cases (Elderly, Comorbidities)

No routine dose adjustment is required for elderly patients or for those with renal impairment.

Use caution in patients with mild to moderate hepatic impairment and avoid use in moderate/severe hepatic disease.

Children are contraindicated and bicalutamide must not be prescribed to this population.

User Testimonials

Positive Reports From UK Patients

Many patients say Casodex provides effective disease control when used with LHRH therapy and appreciate the once‑daily dosing.

Community pharmacists at Boots and LloydsPharmacy often receive thanks for clear counselling and timely repeat supplies.

Regular prostate cancer nurse follow‑up is commonly mentioned as reassuring during the first months of treatment.

Common Challenges (Patient.info, NHS Forums)

Gynecomastia, hot flashes and fatigue are frequently discussed on Patient.info and NHS forum threads.

Some people report mild GI upset early on, usually manageable with simple anti‑nausea measures or taking the tablet with food.

Worry about liver tests is common; patients advise bringing someone to clinic reviews for extra support when results are discussed.

Coping Measures Shared By Patients:

• Use lightweight cooling bedding and layered clothing to manage hot flashes.
• Wear supportive garments or sports vests for breast tenderness or enlargement.
• If nausea occurs, try small, frequent meals and ginger‑based remedies after checking with your pharmacist.

Peer Support:

• Contact your local NHS prostate cancer support group or Macmillan services for local peer contacts and practical tips.

Buying Guide

Pharmacy Sources (Boots, LloydsPharmacy, Superdrug)

Casodex 50 mg is prescription‑only in the UK and supplied by AstraZeneca.

Collect on an NHS prescription from community pharmacies such as Boots, LloydsPharmacy or Superdrug after an electronic prescription transfer or a standard paper prescription.

Accredited online pharmacies may also dispense after electronic prescription transfer; ensure the pharmacy is registered and accredited.

Price Comparison (NHS Prescription Charge Vs Private)

On the NHS the prescription process covers supply and treatment monitoring, subject to the usual prescription charge rules in England.

Prescriptions are free in Scotland, Wales and Northern Ireland.

Private prescription prices vary between pharmacies; always ask for a price breakdown before purchase.

Note About Online Access:

In our online pharmacy, casodex is available without a prescription, with discreet delivery to United Kingdom in 5‑14 days.

What’s Inside & How It Works

Ingredients Overview

The active ingredient is bicalutamide (INN).

The UK product is supplied as 50 mg film‑coated tablets by AstraZeneca.

Check the blister pack leaflet for excipient information if you have known allergies.

Mechanism Basics Explained Simply

Bicalutamide blocks androgen receptors on prostate cancer cells, reducing the action of testosterone at the cell surface.

This anti‑androgen action helps to slow tumour growth and control symptoms driven by androgens.

Because it blocks androgen signalling rather than lowering testosterone production, it is often combined with LHRH analogues to suppress testicular testosterone and give combined blockade.

Main Indications

Approved Uses (MHRA Listing)

Bicalutamide is authorised for prostate cancer indications in the UK and marketed as Casodex 50 mg film‑coated tablets.

The 50 mg dose is commonly used with LHRH analogues for metastatic disease.

The 150 mg dose as monotherapy for locally advanced non‑metastatic disease is used in some regions; confirm with local MHRA/NHS trust guidance.

Off‑Label Uses In UK Clinics

Some centres may consider bicalutamide for symptom control or as part of specific clinical pathways, but newer agents such as enzalutamide and apalutamide are preferred in some indications due to trial data.

Any off‑label use should be documented with informed consent and an agreed monitoring plan between patient and MDT.

Prescribing And Monitoring Checklist:

• Record indication clearly on the prescription or clinic letter.
• Agree baseline investigations and LFT schedule.
• Document informed consent for off‑label use.

Interaction Warnings

Food Interactions (Alcohol, Tea/Coffee)

There are no specific food interactions documented for bicalutamide.

Alcohol can increase fatigue and may add to liver risk; advise moderation, particularly if liver enzymes are elevated.

Normal UK beverages such as tea and coffee do not significantly interfere with treatment.

Drug Conflicts (MHRA Yellow Card Reports)

Bicalutamide can interact with warfarin and other drugs with a narrow therapeutic index; increased monitoring such as INR checks may be required.

Pharmacy teams typically run interaction checks at dispensing; bring a full list of current medicines to each collection.

Report suspected adverse reactions via the MHRA Yellow Card scheme; this helps identify rare interactions or safety signals.

What To Tell Your Pharmacist:

• Any anticoagulant therapy, especially warfarin.
• All current prescription and over‑the‑counter medicines and supplements.
• Any prior liver disease or previous hepatotoxic drug exposure.

Latest Evidence & Insights

UK and EU oncology reviews between 2022–2025 reaffirm that bicalutamide remains a licensed anti‑androgen for defined prostate cancer settings.

Newer second‑generation agents such as enzalutamide and apalutamide now dominate some indications because of improved progression‑free survival in trial data.

Bicalutamide retains a role where cost, tolerability or combination strategies favour older anti‑androgens and where local NHS formularies list it.

If your clinical team suggests Casodex, ask how it compares with alternatives for your disease stage and what monitoring schedule will be used.

Comparative Checklist For Patient Discussion:

• Ask about expected benefits versus newer agents for your specific stage of disease.
• Discuss likelihood of side effects such as gynecomastia and liver enzyme changes.
• Clarify monitoring frequency and who will act on abnormal results.

Alternative Choices

Several NHS alternatives exist depending on disease stage and local commissioning.

Discuss options in your MDT or with your oncologist so the choice matches your comorbidities and the local formulary.

Regulation Snapshot

Bicalutamide (INN) is marketed as Casodex in the UK and classified under ATC L02BB03.

It is prescription‑only and regulated by the MHRA under standard oncology licensing frameworks.

Local NHS trusts apply clinical guidelines and formulary decisions for use and supply.

Prescribing Framework For Clinicians:

• Ensure licence and indication are recorded on the patient record.
• Agree monitoring plan, especially baseline and follow‑up LFTs.
• Provide clear patient information and record any off‑label consent.
• Report suspected adverse reactions via Yellow Card as appropriate.

FAQ Section

Will I Need Liver Tests?

Yes.

Liver function tests are routinely checked at baseline and during early treatment because of the risk of raised ALT and AST.

Can Women Handle Exposure?

No.

Casodex is contraindicated in women and children; avoid giving the tablets to women or children.

How Long Will I Take It?

That Depends On Indication.

Metastatic use often continues until disease progression; locally advanced cases commonly follow defined courses often of at least two years per protocol.

Can I Get It At My Usual Pharmacy?

Yes, With A Valid Prescription.

Community pharmacies dispense on NHS prescriptions; remember that England applies prescription charges unless you are exempt, while Scotland, Wales and Northern Ireland do not charge.

When To Call Your GP Or Oncology Nurse:

• If you develop jaundice, dark urine, severe abdominal pain or vomiting.
• If you experience severe dizziness, collapse or breathing difficulties.
• If you notice new or worsening breast tenderness, major mood changes, or bleeding.

Guidelines For Proper Use

UK Pharmacist Counselling Style

Confirm the indication and dosing time at first collection and with each repeat supply.

Explain missed‑dose advice: take as soon as remembered unless it is nearly time for the next dose; do not double up.

Reiterate storage instructions: keep tablets in original blister and store below 25°C away from light and moisture.

Advise baseline and regular liver function tests and flag any hepatotoxins the patient may be taking.

NHS Patient Support Advice

Encourage registration for repeat prescriptions through GP or hospital electronic systems.

Signpost to Macmillan, hospital prostate cancer nurse specialists and local support groups for symptom control and emotional support.

Advise using the MHRA Yellow Card for suspected adverse reactions; reporting supports safety monitoring.

Practical Checklist Before First Collection:

• Bring the signed prescription and, if relevant, a hospital ID letter.
• Provide a current list of all medicines, including over‑the‑counter drugs and supplements.
• Ensure contact details for the oncology nurse and GP are recorded.

Delivery Across United Kingdom